Quick balloon dilation for removing large bile duct stones

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter Scandinavian study investigates the effectiveness of quick large balloon dilation for the removal of large bile duct stones greater than 10mm in diameter. Patients over 18 years old will undergo endoscopic procedures where the dilation will be performed until the waist of the papilla disappears, as observed through cholangiography. The study aims to assess stone clearance rates and monitor short and long-term adverse events such as pancreatitis, cholangitis, and bleeding. Data will be collected through patient questionnaires and medical records at one month and one year post-procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>18 years
* Common bile duct stone \>10mm diameter

Exclusion Criteria:

* Altered anatomy after surgery (B II, Roux-en-Y reconstruction)
* Common bile duct cysts
* Acute pancreatitis
* Distal common bile duct stricture or tumor
* Coagulation disorders
* Ongoing coagulation medication
* Pregnancy
* Inability to give an informed consent

Where it's running

• Helsinki University Hospital
  Helsinki, Finland Recruiting
• Turku University Hospital
  Turku, Finland Recruiting

Study contacts

• Study coordinator: Mia Rainio, MD, PhD
• Email: mia.rainio@hus.fi
• Phone: +358505833060

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events

  In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.

  Recruiting Phase 4 Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07796217

• Ice water plus NSAIDs to prevent post-ERCP pancreatitis

  This study tests whether adding ice-cold water irrigation to the standard NSAID prevention can further reduce post-ERCP pancreatitis in adults.

  Recruiting Instituto do Cancer do Estado de São Paulo · São Paulo, São Paulo · NCT07738094

• Sedation Methods in PTBD: How Two Regimens Compare for Quality and Recovery

  This study tests two sedation plans (propofol with remifentanil vs propofol with ketamine) to see which helps patients recover faster after PTBD while staying comfortable and safe.

  Recruiting Ankara City Hospital Bilkent · Ankara, Ankara · NCT07640243

• Multi-omics search for clotting and bleeding markers in coronary heart disease

  This project will test whether combining proteins, metabolites, genes, sugar tags, and heart images can better predict clotting and major bleeding in people with coronary heart disease on dual antiplatelet therapy.

  Recruiting at 3 sites Chinese Academy of Medical Sciences, Fuwai Hospital · Zhengzhou, Henan and 2 other locations · NCT07523880

• Apixaban vs Warfarin in HeartMate 3 LVAD Patients

  This study tests whether apixaban can replace warfarin to prevent clots and bleeding problems in adults with an implanted HeartMate 3 LVAD for at least 3 months.

  Recruiting Phase 3 Columbia University · New York, New York · NCT07471139

• Safety of perioperative blood thinner management in people with cancer undergoing surgery or procedures

  This study tests how safe current practices are for stopping or continuing blood thinners in adults with cancer who are having surgery or procedures, to see if bleeding or clots are affected.

  Recruiting Ottawa Hospital Research Institute · Ottawa · NCT07372716

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.